Skip to main content
. 2019 Jan 31;20(3):612. doi: 10.3390/ijms20030612

Table 3.

Comparative percent of expression of the studied markers before and after treatment with dexamethasone.

Cell Marker ALP CD105 CD44 CD90 Osteopontin Osteonectin Osteocalcin RUNX2
BM001 (−) Dexa 65.2% 24.3% 6.9% 88.5% 0.0% 19.2% 20.8% 11.9%
BM001 (+) Dexa 100% 97% 54.7% 91.4% 42.4% 57.6% 56.1% 26.3%
Control Osteoblast 93.9% 96.8% 27.9% 90.1% 84.7% 59.6% 53.3% 43.9%